Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marion Subklewe

Showing results (201-210 of 244) with videos related to

Pageof 25
Sort By:
Science Advances|September 22, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansionKai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Leukemia|April 1, 2025
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapyGloria Iacoboni, Kai Rejeski, Víctor Navarro, et al.
Haematologica|December 16, 2017
A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemiaTobias Herold, Vindi Jurinovic, Aarif M N Batcha, et al.
Molecular Cancer Therapeutics|June 11, 2020
Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid LeukemiaBettina Brauchle, Rebecca L Goldstein, Christine M Karbowski, et al.
Molecular Cell|March 24, 2026
RNF25 confers mRNA damage tolerance by curbing activation of the integrated stress responseShubo Zhao, Chloe S Palma-Chaundler, Carla M Engel, et al.
Journal for Immunotherapy of Cancer|December 4, 2025
TNF-α and IFN-γ differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicityMonika Sponheimer, Kieron White, Michelle Ulrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell LymphomaKhushali Jhaveri, Ram Thapa, Dalia Ercan, et al.
Leukemia|July 1, 2026
Feasibility and safety of rapid glofitamab ramp-upCeline H Liem, Rebecca Wurm-Kuczera, David Böckle, et al.
Science Advances|June 10, 2021
Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumorsBruno L Cadilha, Mohamed-Reda Benmebarek, Klara Dorman, et al.
Blood|January 22, 2025
Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE2 signaling in NK cellsCharlotte Rothfuß, Tobias Baumann, Sainitin Donakonda, et al.
Pageof 25

Showing results (201-210 of 244) with videos related to

Sort By:
Pageof 25
Science Advances|September 22, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansionKai Rejeski, Ariel Perez, Gloria Iacoboni, et al.
Leukemia|April 1, 2025
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapyGloria Iacoboni, Kai Rejeski, Víctor Navarro, et al.
Haematologica|December 16, 2017
A 29-gene and cytogenetic score for the prediction of resistance to induction treatment in acute myeloid leukemiaTobias Herold, Vindi Jurinovic, Aarif M N Batcha, et al.
Molecular Cancer Therapeutics|June 11, 2020
Characterization of a Novel FLT3 BiTE Molecule for the Treatment of Acute Myeloid LeukemiaBettina Brauchle, Rebecca L Goldstein, Christine M Karbowski, et al.
Molecular Cell|March 24, 2026
RNF25 confers mRNA damage tolerance by curbing activation of the integrated stress responseShubo Zhao, Chloe S Palma-Chaundler, Carla M Engel, et al.
Journal for Immunotherapy of Cancer|December 4, 2025
TNF-α and IFN-γ differentially regulate AML cell susceptibility to CD70-antibody-mediated cytotoxicityMonika Sponheimer, Kieron White, Michelle Ulrich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2025
Sarcopenia and Skeletal Muscle Loss after CAR T-cell Therapy in Diffuse Large B cell LymphomaKhushali Jhaveri, Ram Thapa, Dalia Ercan, et al.
Leukemia|July 1, 2026
Feasibility and safety of rapid glofitamab ramp-upCeline H Liem, Rebecca Wurm-Kuczera, David Böckle, et al.
Science Advances|June 10, 2021
Combined tumor-directed recruitment and protection from immune suppression enable CAR T cell efficacy in solid tumorsBruno L Cadilha, Mohamed-Reda Benmebarek, Klara Dorman, et al.
Blood|January 22, 2025
Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE2 signaling in NK cellsCharlotte Rothfuß, Tobias Baumann, Sainitin Donakonda, et al.
Pageof 25